Transcutaneous vagal nerve simulation to reduce a systemic inflammatory response syndrome and the associated intestinal failure: study protocol of a prospective, two-armed, sham-controlled, double-blinded trial in healthy subjects (the NeuroSIRS-Study)
Purpose Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurost...
Saved in:
Published in | International journal of colorectal disease Vol. 37; no. 1; pp. 259 - 270 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.01.2022
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0179-1958 1432-1262 1432-1262 |
DOI | 10.1007/s00384-021-04034-1 |
Cover
Loading…
Abstract | Purpose
Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis.
Methods
The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed.
Discussion
TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. |
---|---|
AbstractList | Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis.
The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed.
TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. PurposeSurgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis.MethodsThe NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed.DiscussionTaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis. The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed. TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. Purpose Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis. Methods The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed. Discussion TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. Purpose Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis. Methods The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed. Discussion TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis.PURPOSESurgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis and breakdown of intestinal barrier and might result in abdominal sepsis. Technological progress led to the development of a neurostimulator for transcutaneous auricular vagal nerve stimulation (taVNS), which is associated with a decline in inflammatory parameters and peristalsis improvement in rodents and healthy subjects via activation of the cholinergic anti-inflammatory pathway. Therefore, taVNS might be a strategy for SIRS prophylaxis.The NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed.METHODSThe NeuroSIRS-Study is a prospective, randomized two-armed, sham-controlled, double-blind clinical trial. The study is registered at DRKS00016892 (09.07.2020). A controlled endotoxemia is used as a SIRS-mimicking model. 2 ng/kg bodyweight lipopolysaccharide (LPS) will be administered after taVNS or sham stimulation. The primary objective is a reduction of clinical symptoms of SIRS after taVNS compared to sham stimulation. Effects of taVNS on release of inflammatory cytokines, intestinal function, and vital parameters will be analyzed.TaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches.DISCUSSIONTaVNS is well-tolerated, with little to no side effects. Despite not fully mimicking postoperative inflammation, LPS challenge is the most used experimental tool to imitate SIRS and offers standardization and reproducibility. The restriction to healthy male volunteers exerts a certain bias limiting generalizability to the surgical population. Still, this pilot study aims to give first insights into taVNS as a prophylactic treatment in postoperative inflammation to pave the way for further clinical trials in patients at risk for SIRS. This would have major implications for future therapeutic approaches. |
Audience | Academic |
Author | Panknin, Christina Vilz, Tim O. van Beekum, Cornelius J. Willis, Maria A. Wehner, Sven Kalff, Jörg C. von Websky, Martin W. Coenen, Martin Fimmers, Rolf |
Author_xml | – sequence: 1 givenname: Cornelius J. orcidid: 0000-0002-3347-2675 surname: van Beekum fullname: van Beekum, Cornelius J. organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn – sequence: 2 givenname: Martin W. surname: von Websky fullname: von Websky, Martin W. organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn – sequence: 3 givenname: Maria A. surname: Willis fullname: Willis, Maria A. organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn – sequence: 4 givenname: Christina surname: Panknin fullname: Panknin, Christina organization: Clinical Study Core Unit, Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital of Bonn – sequence: 5 givenname: Martin surname: Coenen fullname: Coenen, Martin organization: Clinical Study Core Unit, Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital of Bonn – sequence: 6 givenname: Rolf surname: Fimmers fullname: Fimmers, Rolf organization: Clinical Study Core Unit, Institute of Medical Biometrics, Informatics and Epidemiology, Study Center, University Hospital of Bonn – sequence: 7 givenname: Jörg C. surname: Kalff fullname: Kalff, Jörg C. organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn – sequence: 8 givenname: Sven surname: Wehner fullname: Wehner, Sven organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn – sequence: 9 givenname: Tim O. surname: Vilz fullname: Vilz, Tim O. email: tim.vilz@ukbonn.de organization: Department of General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34599686$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktr3DAUhU1JaR7tH-iiCLpJIU4lW5bsLgoh9BEILXTStdBI8owGWZpI8pT57130OpM0TSjBCyHpO-f66p7DYs8Hb4riNcGnBGP-PmFct7TEFSkxxTUtybPigNC6KknFqr3iABPelaRr2v3iMKUVhj3j9EWxX9Om61jLDorfV1H6pMYsvQljQhu5kA55EzcGJTuMTmYbPMoBRaNHZZBEaZuyGaxC1vdODoPMIW7hOq2DT6Daeh3DAKTXKC9hTSkoK7PRoMgmZeuhRC-tG6P5gFIe9RatY8hBBYdCDyVgl9ZGZbsxJyj_CqWMg9EnKC3lUKrgcwzOTQc6jHNnyrmzXoN_jhasrUdLI11eblEa5yvwSeh4-pNvZoxhdvFjVs6mou9eFs976ZJ5dbseFT8_f7o6_1pefv9ycX52WaqGklxqxmsu512jGJZEs7qf86ZqpNYta4ypuxq3dEIbpivK2powzKWSEnMKm7Y-Kj7ufNfjHPpQBhqQTqyjHWTciiCteHjj7VIswka0nOEKEzA4vjWI4XqEJxSDTco4t5uaqBoOKOvYhL59hK7CGOHFgWKk45TjurmnYNpGwCAD1FWTqTjjhNKW44YCdfofCj49zR_C2Fs4fyB482-jfzu8yxsA7Q5QMOEUTS-UzTcRA2frBMFiirbYRVtAtMVNtMXUWPVIeuf-pKjeiRLAfmHi_Ws8ofoDlsEQuA |
CitedBy_id | crossref_primary_10_3390_biomed3040039 crossref_primary_10_3389_felec_2025_1503425 crossref_primary_10_1002_cam4_6466 |
Cites_doi | 10.1016/j.jacep.2019.11.008 10.2174/092986708784872393 10.1055/s-0029-1237374 10.1067/mva.2000.107562 10.1111/nmo.13501 10.1073/pnas.1605635113 10.1016/j.molmet.2017.10.002 10.1111/nmo.13407 10.1016/j.brs.2014.11.018 10.1136/flgastro-2017-100809 10.1111/j.1365-2362.2011.02485.x 10.1038/nri.2016.90 10.1016/j.brainres.2011.04.034 10.1378/chest.112.1.235 10.1093/bja/aex239 10.1016/j.bbi.2015.08.013 10.1136/bmjopen-2015-011014 10.1016/j.jcin.2017.04.036 10.1136/annrheumdis-2020-217872 10.3389/fnins.2019.00772 10.1186/1479-5876-11-63 10.1016/j.brs.2016.10.008 10.1007/s00268-020-05543-w 10.1097/00024382-200115010-00001 10.1111/j.1365-2796.2010.02321.x 10.1371/journal.pone.0220397 10.1053/j.gastro.2007.07.022 10.1152/ajpgi.00426.2020 10.1177/09680519000060040501 10.1097/SHK.0000000000000063 10.1016/0920-1211(94)90007-8 10.1186/s13054-014-0721-8 10.1111/nmo.12999 10.1038/nrgastro.2012.134 10.1111/codi.15561 10.1097/SHK.0b013e3182168d56 10.2741/1816 10.1007/s00384-018-3204-6 10.1111/nmo.12792 10.1016/j.jad.2016.02.031 10.1016/j.ejpn.2016.02.014 10.1038/35013070 10.1001/jamasurg.2020.0808 10.1111/nmo.13075 10.1159/000435843 10.1016/j.jacc.2014.12.026 10.1016/j.injury.2007.10.003 10.1016/j.jinf.2016.11.006 10.1002/ca.1089 10.1111/j.1476-5381.2011.01296.x 10.1186/s13075-015-0667-5 10.1007/s00134-004-2477-0 10.1177/0968051907085986 10.1017/S0033291707001924 10.1111/bcp.13941 10.1097/SHK.0b013e318299e9c0 10.1111/j.1365-2982.2010.01653.x 10.1111/nmo.12760 10.1177/000313481207800102 10.1113/EP086433 10.1515/BMT.2008.022 10.1089/sur.2012.155 10.1111/j.1528-1167.2012.03492.x 10.1186/s10194-015-0543-3 10.1016/j.brs.2017.12.009 10.1111/j.1528-1157.1999.tb02019.x |
ContentType | Journal Article |
Copyright | The Author(s) 2021 2021. The Author(s). COPYRIGHT 2022 Springer The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: COPYRIGHT 2022 Springer – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 5PM |
DOI | 10.1007/s00384-021-04034-1 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1262 |
EndPage | 270 |
ExternalDocumentID | PMC8760201 A714487054 34599686 10_1007_s00384_021_04034_1 |
Genre | Clinical Trial Protocol Journal Article |
GrantInformation_xml | – fundername: Faculty of Medicine of the University of Bonn grantid: 2017-FKS-05 – fundername: Universitätsklinikum Bonn (8930) – fundername: ; – fundername: ; grantid: 2017-FKS-05 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHNG AAIAL AAJKR AAJSJ AAKKN AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMOR ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACACY ACBXY ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACUDM ACULB ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFGXO AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C24 C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7V Z7W Z7X Z82 Z87 Z8O Z8P Z8Q Z8V Z91 ZMTXR ZOVNA ~EX ~KM AAFWJ AASML AAYXX ABDBE ABFSG ACSTC ADHKG AEZWR AFHIU AGQPQ AHPBZ AHWEU AIXLP AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB 7T5 H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c541t-d6737ab95c60a1d63fb7525add865ee393084c54156d246831607acaa07483183 |
IEDL.DBID | C6C |
ISSN | 0179-1958 1432-1262 |
IngestDate | Thu Aug 21 14:14:15 EDT 2025 Thu Sep 04 20:41:21 EDT 2025 Thu Aug 28 18:07:20 EDT 2025 Tue Jun 17 21:40:15 EDT 2025 Tue Jun 10 20:28:31 EDT 2025 Thu Apr 03 07:02:01 EDT 2025 Tue Jul 01 04:24:37 EDT 2025 Thu Apr 24 22:53:59 EDT 2025 Fri Feb 21 02:46:50 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | SIRS Intestinal barrier Inflammation Vagal nerve stimulation Ileus Cholinergic anti-inflammatory pathway |
Language | English |
License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-d6737ab95c60a1d63fb7525add865ee393084c54156d246831607acaa07483183 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0002-3347-2675 |
OpenAccessLink | https://doi.org/10.1007/s00384-021-04034-1 |
PMID | 34599686 |
PQID | 2619747035 |
PQPubID | 31377 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8760201 proquest_miscellaneous_2578766961 proquest_journals_2619747035 gale_infotracmisc_A714487054 gale_infotracacademiconefile_A714487054 pubmed_primary_34599686 crossref_citationtrail_10_1007_s00384_021_04034_1 crossref_primary_10_1007_s00384_021_04034_1 springer_journals_10_1007_s00384_021_04034_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: New York |
PublicationSubtitle | Clinical and Molecular Gastroenterology and Surgery |
PublicationTitle | International journal of colorectal disease |
PublicationTitleAbbrev | Int J Colorectal Dis |
PublicationTitleAlternate | Int J Colorectal Dis |
PublicationYear | 2022 |
Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
References | Aranow, Atish-Fregoso, Lesser, Mackay, Anderson, Chavan (CR53) 2021; 80 Gao, Li, Liu, Rong, Ben, Li (CR19) 2011; 1397 Koopman, Chavan, Miljko, Grazio, Sokolovic, Schuurman (CR16) 2016; 113 Stakenborg, Wolthuis, Gomez-Pinilla, Farro, Di Giovangiulio, Bosmans (CR13) 2017; 29 Wegeberg, Brock, Brock, Farmer, Hobson, Semler (CR69) 2018; 30 Salama, Akan, Mueller (CR60) 2020; 44 Bonaz, Sinniger, Hoffmann, Clarencon, Mathieu, Dantzer (CR17) 2016; 28 Hong, Pintea, Lingohr, Coch, Randau, Schaefer (CR30) 2019; 34 Fry (CR3) 2012; 78 Rong, Liu, Wang, Liu, Fang, Zhao (CR26) 2016; 195 Dieleman, Peelen, Coulson, Tran, Reid, Smith (CR42) 2017; 119 Bamdad, Englesbe (CR65) 2020; 155 Huston, Tracey (CR44) 2011; 269 Frangos, Ellrich, Komisaruk (CR21) 2015; 8 Fullerton, Segre, De Maeyer, Maini, Gilroy (CR34) 2016; 111 Kox, Pickkers (CR37) 2015; 131 Kox, van Eijk, Verhaak, Frenzel, Kiers, Gerretsen (CR39) 2015; 17 Huston, Gallowitsch-Puerta, Ochani, Ochani, Yuan, Rosas-Ballina (CR54) 2007; 35 Vilz, Pantelis, Lingohr, Fimmers, Esmann, Randau (CR36) 2016; 6 The, Cailotto, Van Der Vliet, De Jonge, Bennink, Buijs (CR12) 2011; 163 Zhu, Xu, Lu, Rong, Cheng, Li (CR28) 2021; 320 van Beekum, Esmann, Heinze, von Websky, Stoffels, Wehner (CR35) 2021; 62 Musa, Kabir, Hossain, Ahmed, Siddique, Rashid (CR62) 2019; 14 Ferguson, Patel, Shah, Mulvey, Gadi, Nijjar (CR66) 2013; 11 Zhou, Liang, Li, Xiang, Liu, Li (CR15) 2013; 40 van Groenendael, Kox, Leijte, Koeneman, Gerretsen, van Eijk (CR40) 2019; 85 Peuker, Filler (CR18) 2002; 15 Van Bree, Nemethova, Cailotto, Gomez-Pinilla, Matteoli, Boeckxstaens (CR10) 2012; 9 Hassoun, Kone, Mercer, Moody, Weisbrodt, Moore (CR4) 2001; 15 Andreasen, Krabbe, Krogh-Madsen, Taudorf, Pedersen, Moller (CR48) 2008; 15 Deitch, Xu, Kaise (CR6) 2006; 11 Klein, Flanagan (CR68) 2016; 16 Borovikova, Ivanova, Zhang, Yang, Botchkina, Watkins (CR9) 2000; 405 Lenz, Franklin, Cheadle (CR1) 2007; 38 Kamisoglu, Sleight, Calvano, Coyle, Corbett, Androulakis (CR45) 2013; 40 Badran, Dowdle, Mithoefer, LaBate, Coatsworth, Brown (CR22) 2018; 11 Straube, Ellrich, Eren, Blum, Ruscheweyh (CR23) 2015; 16 Williams, Fullerton, Fox, Enslin, Murray, Jorkasky (CR63) 2000; 6 Schlaepfer, Frick, Zobel, Maier, Heuser, Bajbouj (CR56) 2008; 38 Bone, Grodzin, Balk (CR41) 1997; 112 Deuchars, Lall, Clancy, Mahadi, Murray, Peers (CR51) 2018; 103 Gancheva, Bierwagen, Markgraf, Bönhof, Murphy, Hatziagelaki (CR49) 2018; 7 Shimizu, Ogura, Asahara, Nomoto, Morotomi, Nakahori (CR5) 2011; 23 Chapman, Helliwell, Naylor, Tassinari, Corrigan, Jayne (CR61) 2021; 23 Arefian, Heublein, Scherag, Brunkhorst, Younis, Moerer (CR8) 2017; 74 Kaniusas, Kampusch, Tittgemeyer, Panetsos, Gines, Papa (CR52) 2019; 13 Lötvall, Lunde, Augustinson, Hedner, Svedmyr, Ben-Menachem (CR59) 1994; 18 Kox, Pompe, de Gouberville, van der Hoeven, Hoedemaekers, Pickkers (CR38) 2011; 36 Paulon, Nastou, Jaboli, Marin, Liebler, Epstein (CR29) 2017; 8 Sperling, Reulbach, Bleich, Padberg, Kornhuber, Mueck-Weymann (CR55) 2010; 43 The, Boeckxstaens, Snoek, Cash, Bennink, LaRosa (CR11) 2007; 133 Engler, Benson, Wegner, Spreitzer, Schedlowski, Elsenbruch (CR67) 2016; 52 Stefan, Kreiselmeyer, Kerling, Kurzbuch, Rauch, Heers (CR24) 2012; 53 Stavrakis, Stoner, Humphrey, Morris, Filiberti, Reynolds (CR25) 2020; 6 Brock, Brock, Aziz, Møller, Pfeiffer Jensen, Drewes (CR33) 2017; 29 van Eijk, Pickkers, Smits, Bouw, van der Hoeven (CR64) 2004; 30 Haarala, Kähönen, Eklund, Jylhävä, Koskinen, Taittonen (CR43) 2011; 41 Calvano, Coyle (CR47) 2012; 13 Velasco, Leitão, Leitão, Dalcomune, Massete (CR7) 2015; 19 Hong, Zillekens, Schneiker, Pantelis, de Jonge, Schaefer (CR14) 2019; 31 Yu, Huang, Po, Tan, Wang, Zhou (CR31) 2017; 10 Dietrich, Smith, Scherzinger, Hofmann-Preiss, Freitag, Eisenkolb (CR50) 2008; 53 Galle, De Maertelaer, Motte, Zhou, Stordeur, Delville (CR2) 2000; 32 Frangos, Komisaruk (CR20) 2017; 10 Bahador, Cross (CR46) 2007; 13 Asconapé, Moore, Zipes, Hartman, Duffell (CR57) 1999; 40 Cantarín-Extremera, Ruíz-Falcó-Rojas, Tamaríz-Martel-Moreno, García-Fernández, Duat-Rodriguez, Rivero-Martín (CR58) 2016; 20 Frøkjaer, Bergmann, Brock, Madzak, Farmer, Ellrich (CR27) 2016; 28 Stavrakis, Humphrey, Scherlag, Hu, Jackman, Nakagawa (CR32) 2015; 65 BW Badran (4034_CR22) 2018; 11 LV Borovikova (4034_CR9) 2000; 405 M Salama (4034_CR60) 2020; 44 MA Musa (4034_CR62) 2019; 14 HT Hassoun (4034_CR4) 2001; 15 H Engler (4034_CR67) 2016; 52 R van Groenendael (4034_CR40) 2019; 85 S Stavrakis (4034_CR25) 2020; 6 TE Schlaepfer (4034_CR56) 2008; 38 JF Ferguson (4034_CR66) 2013; 11 JM Dieleman (4034_CR42) 2017; 119 A Andreasen (4034_CR48) 2008; 15 W Sperling (4034_CR55) 2010; 43 M Kox (4034_CR37) 2015; 131 MC Bamdad (4034_CR65) 2020; 155 FA Koopman (4034_CR16) 2016; 113 E Kaniusas (4034_CR52) 2019; 13 MB Velasco (4034_CR7) 2015; 19 C Galle (4034_CR2) 2000; 32 GS Hong (4034_CR30) 2019; 34 J Lötvall (4034_CR59) 1994; 18 Y Zhu (4034_CR28) 2021; 320 JN Fullerton (4034_CR34) 2016; 111 GS Hong (4034_CR14) 2019; 31 F The (4034_CR12) 2011; 163 A Straube (4034_CR23) 2015; 16 EA Deitch (4034_CR6) 2006; 11 M Kox (4034_CR38) 2011; 36 A-ML Wegeberg (4034_CR69) 2018; 30 M Kox (4034_CR39) 2015; 17 SH Van Bree (4034_CR10) 2012; 9 WV Williams (4034_CR63) 2000; 6 LT van Eijk (4034_CR64) 2004; 30 K Kamisoglu (4034_CR45) 2013; 40 JM Huston (4034_CR44) 2011; 269 S Dietrich (4034_CR50) 2008; 53 FO The (4034_CR11) 2007; 133 H Zhou (4034_CR15) 2013; 40 C Aranow (4034_CR53) 2021; 80 RC Bone (4034_CR41) 1997; 112 P Rong (4034_CR26) 2016; 195 JM Huston (4034_CR54) 2007; 35 S Stavrakis (4034_CR32) 2015; 65 M Bahador (4034_CR46) 2007; 13 E Frangos (4034_CR21) 2015; 8 DE Fry (4034_CR3) 2012; 78 A Haarala (4034_CR43) 2011; 41 K Shimizu (4034_CR5) 2011; 23 N Stakenborg (4034_CR13) 2017; 29 S Gancheva (4034_CR49) 2018; 7 E Paulon (4034_CR29) 2017; 8 SJ Chapman (4034_CR61) 2021; 23 E Frangos (4034_CR20) 2017; 10 SA Deuchars (4034_CR51) 2018; 103 V Cantarín-Extremera (4034_CR58) 2016; 20 A Lenz (4034_CR1) 2007; 38 H Arefian (4034_CR8) 2017; 74 SE Calvano (4034_CR47) 2012; 13 ET Peuker (4034_CR18) 2002; 15 SL Klein (4034_CR68) 2016; 16 C Brock (4034_CR33) 2017; 29 XY Gao (4034_CR19) 2011; 1397 JJ Asconapé (4034_CR57) 1999; 40 B Bonaz (4034_CR17) 2016; 28 H Stefan (4034_CR24) 2012; 53 L Yu (4034_CR31) 2017; 10 CJ van Beekum (4034_CR35) 2021; 62 TO Vilz (4034_CR36) 2016; 6 J Frøkjaer (4034_CR27) 2016; 28 |
References_xml | – volume: 163 start-page: 1007 issue: 5 year: 2011 end-page: 1016 ident: CR12 article-title: Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus publication-title: Br J Pharmacol – volume: 38 start-page: 651 issue: 5 year: 2008 end-page: 661 ident: CR56 article-title: Vagus nerve stimulation for depression: efficacy and safety in a European study publication-title: Psychol Med – volume: 133 start-page: 1219 issue: 4 year: 2007 end-page: 1228 ident: CR11 article-title: Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice publication-title: Gastroenterology – volume: 131 start-page: 79 issue: 2 year: 2015 end-page: 84 ident: CR37 article-title: Modulation of the innate immune response through the vagus nerve publication-title: Nephron – volume: 10 start-page: 1511 issue: 15 year: 2017 end-page: 1520 ident: CR31 article-title: Low-level tragus stimulation for the treatment of ischemia and reperfusion injury in patients with ST-segment elevation myocardial infarction: a proof-of-concept study publication-title: JACC Cardiovasc Interv – volume: 111 start-page: e53913 year: 2016 ident: CR34 article-title: Intravenous endotoxin challenge in healthy humans: an experimental platform to investigate and modulate systemic inflammation publication-title: J Vis Exp – volume: 15 start-page: 1697 issue: 17 year: 2008 end-page: 1705 ident: CR48 article-title: Human endotoxemia as a model of systemic inflammation publication-title: Curr Med Chem – volume: 80 start-page: 203 issue: 2 year: 2021 end-page: 208 ident: CR53 article-title: Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial publication-title: Ann Rheum Dis – volume: 8 start-page: 624 issue: 3 year: 2015 end-page: 636 ident: CR21 article-title: Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans publication-title: Brain Stimul – volume: 28 start-page: 592 issue: 4 year: 2016 end-page: 598 ident: CR27 article-title: Modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity publication-title: Neurogastroenterol Motil – volume: 8 start-page: 325 issue: 4 year: 2017 end-page: 330 ident: CR29 article-title: Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis publication-title: Frontline Gastroenterology – volume: 34 start-page: 417 issue: 3 year: 2019 end-page: 422 ident: CR30 article-title: Effect of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract (transVaGa): a prospective clinical trial publication-title: Int J Colorectal Dis – volume: 11 start-page: 520 issue: 1 year: 2006 end-page: 528 ident: CR6 article-title: Role of the gut in the development of injury-and shock induced SIRS and MODS: the gut-lymph hypothesis, a review publication-title: Front Biosci – volume: 29 start-page: e12999 issue: 5 year: 2017 ident: CR33 article-title: Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor-alpha publication-title: Neurogastroenterol Motil – volume: 29 start-page: e13075 issue: 9 year: 2017 ident: CR13 article-title: Abdominal vagus nerve stimulation as a new therapeutic approach to prevent postoperative ileus publication-title: Neurogastroenterol Motil – volume: 113 start-page: 8284 issue: 29 year: 2016 end-page: 8289 ident: CR16 article-title: Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis publication-title: Proc Natl Acad Sci – volume: 7 start-page: 71 year: 2018 end-page: 79 ident: CR49 article-title: Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos(®) on parasympathetic tone and hepatic energy metabolism publication-title: Mol Metab – volume: 23 start-page: 330 issue: 4 year: 2011 end-page: e157 ident: CR5 article-title: Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study publication-title: Neurogastroenterol Motil – volume: 74 start-page: 107 issue: 2 year: 2017 end-page: 117 ident: CR8 article-title: Hospital-related cost of sepsis: a systematic review publication-title: J Infect – volume: 195 start-page: 172 year: 2016 end-page: 179 ident: CR26 article-title: Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study publication-title: J Affect Disord – volume: 13 start-page: 772 year: 2019 ident: CR52 article-title: Current directions in the auricular vagus nerve stimulation II - an engineering perspective publication-title: Front Neurosci – volume: 320 start-page: 700 issue: 5 year: 2021 end-page: 711 ident: CR28 article-title: Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 18 start-page: 149 issue: 2 year: 1994 end-page: 154 ident: CR59 article-title: Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures publication-title: Epilepsy Res – volume: 44 start-page: 3167 issue: 9 year: 2020 end-page: 3174 ident: CR60 article-title: Transcutaneous stimulation of auricular branch of the vagus nerve attenuates the acute inflammatory response after lung lobectomy publication-title: World J Surg – volume: 16 start-page: 63 issue: 1 year: 2015 ident: CR23 article-title: Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial publication-title: J Headache Pain – volume: 35 start-page: 2762 issue: 12 year: 2007 end-page: 2768 ident: CR54 article-title: Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis publication-title: Crit Care Med – volume: 9 start-page: 675 issue: 11 year: 2012 end-page: 683 ident: CR10 article-title: New therapeutic strategies for postoperative ileus publication-title: Nat Rev Gastroenterol Hepatol – volume: 62 start-page: 1 issue: 2 year: 2021 end-page: 9 ident: CR35 article-title: Safety and suitability of the SmartPill® after Abdominal surgery: results of the prospective, two-armed, open-label PIDuSA trial publication-title: Eur Surg Res – volume: 52 start-page: 18 year: 2016 end-page: 26 ident: CR67 article-title: Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms publication-title: Brain Behav Immun – volume: 6 start-page: e011014 issue: 7 year: 2016 ident: CR36 article-title: SmartPill® as an objective parameter for determination of severity and duration of postoperative ileus: study protocol of a prospective, two-arm, open-label trial (the PIDuSA study) publication-title: BMJ Open – volume: 40 start-page: 519 issue: 6 year: 2013 ident: CR45 article-title: Temporal metabolic profiling of plasma during endotoxemia in humans publication-title: Shock (Augusta, Ga) – volume: 10 start-page: 19 issue: 1 year: 2017 end-page: 27 ident: CR20 article-title: Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans publication-title: Brain Stimul – volume: 13 start-page: 293 issue: 5 year: 2012 end-page: 299 ident: CR47 article-title: Experimental human endotoxemia: a model of the systemic inflammatory response syndrome? publication-title: Surg Infect – volume: 40 start-page: 144 issue: 2 year: 2013 end-page: 151 ident: CR15 article-title: Vagus nerve stimulation attenuates intestinal epithelial tight junctions disruption in endotoxemic mice through α7 nicotinic acetylcholine receptors publication-title: Shock – volume: 23 start-page: 1225 issue: 5 year: 2021 end-page: 1232 ident: CR61 article-title: Noninvasive vagus nerve stimulation to reduce ileus after major colorectal surgery: early development study publication-title: Colorectal Dis – volume: 43 start-page: 7 issue: 01 year: 2010 end-page: 11 ident: CR55 article-title: Cardiac effects of vagus nerve stimulation in patients with major depression publication-title: Pharmacopsychiatry – volume: 28 start-page: 948 issue: 6 year: 2016 end-page: 953 ident: CR17 article-title: Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study publication-title: Neurogastroenterol Motil – volume: 15 start-page: 35 issue: 1 year: 2002 end-page: 37 ident: CR18 article-title: The nerve supply of the human auricle publication-title: Clin Anat – volume: 38 start-page: 1336 issue: 12 year: 2007 end-page: 1345 ident: CR1 article-title: Systemic inflammation after trauma publication-title: Injury – volume: 30 start-page: 2279 issue: 12 year: 2004 end-page: 2281 ident: CR64 article-title: Severe vagal response after endotoxin administration in humans publication-title: Intensive Care Med – volume: 11 start-page: 63 issue: 1 year: 2013 ident: CR66 article-title: Race and gender variation in response to evoked inflammation publication-title: J Transl Med – volume: 17 start-page: 150 issue: 1 year: 2015 ident: CR39 article-title: Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study publication-title: Arthritis Res Ther – volume: 36 start-page: 5 issue: 1 year: 2011 end-page: 11 ident: CR38 article-title: Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans publication-title: Shock – volume: 53 start-page: 104 issue: 3 year: 2008 end-page: 111 ident: CR50 article-title: A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI publication-title: Biomed Tech (Berl) – volume: 30 start-page: e13407 issue: 11 year: 2018 ident: CR69 article-title: Regional gastrointestinal pH profile is altered in patients with type 1 diabetes and peripheral neuropathy publication-title: Neurogastroenterol Motil – volume: 32 start-page: 234 issue: 2 year: 2000 end-page: 246 ident: CR2 article-title: Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery publication-title: J Vasc Surg – volume: 16 start-page: 626 issue: 10 year: 2016 end-page: 638 ident: CR68 article-title: Sex differences in immune responses publication-title: Nat Rev Immunol – volume: 155 start-page: 799 issue: 9 year: 2020 end-page: 800 ident: CR65 article-title: Surgery and population health—redesigning surgical quality for greater impact publication-title: JAMA Surg – volume: 405 start-page: 458 issue: 6785 year: 2000 end-page: 462 ident: CR9 article-title: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin publication-title: Nature – volume: 31 start-page: e13501 issue: 3 year: 2019 ident: CR14 article-title: Non-invasive transcutaneous auricular vagus nerve stimulation prevents postoperative ileus and endotoxemia in mice publication-title: Neurogastroenterol Motil – volume: 14 start-page: e0220397 issue: 8 year: 2019 ident: CR62 article-title: Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS publication-title: PLoS ONE – volume: 103 start-page: 326 issue: 3 year: 2018 end-page: 331 ident: CR51 article-title: Mechanisms underpinning sympathetic nervous activity and its modulation using transcutaneous vagus nerve stimulation publication-title: Exp Physiol – volume: 6 start-page: 282 issue: 3 year: 2020 end-page: 291 ident: CR25 article-title: TREAT AF (transcutaneous electrical vagus nerve stimulation to suppress atrial fibrillation): a randomized clinical trial publication-title: JACC Clin Electrophysiol – volume: 15 start-page: 1 issue: 1 year: 2001 end-page: 10 ident: CR4 article-title: Post-injury multiple organ failure: the role of the gut publication-title: Shock (Augusta, Ga) – volume: 41 start-page: 951 issue: 9 year: 2011 end-page: 957 ident: CR43 article-title: Heart rate variability is independently associated with C-reactive protein but not with serum amyloid A. The Cardiovascular Risk in Young Finns Study publication-title: Eur J Clin Invest – volume: 11 start-page: 492 issue: 3 year: 2018 end-page: 500 ident: CR22 article-title: Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: a concurrent taVNS/fMRI study and review publication-title: Brain Stimul – volume: 269 start-page: 45 issue: 1 year: 2011 end-page: 53 ident: CR44 article-title: The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy publication-title: J Intern Med – volume: 112 start-page: 235 issue: 1 year: 1997 end-page: 243 ident: CR41 article-title: Sepsis: a new hypothesis for pathogenesis of the disease process publication-title: Chest – volume: 78 start-page: 1 issue: 1 year: 2012 end-page: 8 ident: CR3 article-title: Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues publication-title: Am Surg – volume: 65 start-page: 867 issue: 9 year: 2015 end-page: 875 ident: CR32 article-title: Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation publication-title: J Am Coll Cardiol – volume: 20 start-page: 678 issue: 4 year: 2016 end-page: 683 ident: CR58 article-title: Late-onset periodic bradycardia during vagus nerve stimulation in a pediatric patient A new case and review of the literature publication-title: Eur J Paediatr Neurol – volume: 19 start-page: 1 issue: 1 year: 2015 end-page: 201 ident: CR7 article-title: Evaluation of the cost of severe sepsis and septic shock in a private ICU in Brazil publication-title: Crit Care – volume: 85 start-page: 1559 issue: 7 year: 2019 end-page: 1571 ident: CR40 article-title: A randomized double-blind, placebo-controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA-230 during experimental human endotoxaemia publication-title: Br J Clin Pharmacol – volume: 53 start-page: e115 issue: 7 year: 2012 end-page: e118 ident: CR24 article-title: Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial publication-title: Epilepsia – volume: 13 start-page: 251 issue: 5 year: 2007 end-page: 279 ident: CR46 article-title: From therapy to experimental model: a hundred years of endotoxin administration to human subjects publication-title: J Endotoxin Res – volume: 6 start-page: 303 issue: 4 year: 2000 end-page: 306 ident: CR63 article-title: Asystole following endotoxin administration publication-title: J Endotoxin Res – volume: 1397 start-page: 19 year: 2011 end-page: 27 ident: CR19 article-title: Acupuncture-like stimulation at auricular point Heart evokes cardiovascular inhibition via activating the cardiac-related neurons in the nucleus tractus solitarius publication-title: Brain Res – volume: 40 start-page: 1452 issue: 10 year: 1999 end-page: 1454 ident: CR57 article-title: Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing publication-title: Epilepsia – volume: 119 start-page: 637 issue: 4 year: 2017 end-page: 644 ident: CR42 article-title: Age and other perioperative risk factors for postoperative systemic inflammatory response syndrome after cardiac surgery publication-title: Br J Anaesth – volume: 35 start-page: 2762 issue: 12 year: 2007 ident: 4034_CR54 publication-title: Crit Care Med – volume: 6 start-page: 282 issue: 3 year: 2020 ident: 4034_CR25 publication-title: JACC Clin Electrophysiol doi: 10.1016/j.jacep.2019.11.008 – volume: 15 start-page: 1697 issue: 17 year: 2008 ident: 4034_CR48 publication-title: Curr Med Chem doi: 10.2174/092986708784872393 – volume: 43 start-page: 7 issue: 01 year: 2010 ident: 4034_CR55 publication-title: Pharmacopsychiatry doi: 10.1055/s-0029-1237374 – volume: 32 start-page: 234 issue: 2 year: 2000 ident: 4034_CR2 publication-title: J Vasc Surg doi: 10.1067/mva.2000.107562 – volume: 31 start-page: e13501 issue: 3 year: 2019 ident: 4034_CR14 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13501 – volume: 113 start-page: 8284 issue: 29 year: 2016 ident: 4034_CR16 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1605635113 – volume: 7 start-page: 71 year: 2018 ident: 4034_CR49 publication-title: Mol Metab doi: 10.1016/j.molmet.2017.10.002 – volume: 30 start-page: e13407 issue: 11 year: 2018 ident: 4034_CR69 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13407 – volume: 8 start-page: 624 issue: 3 year: 2015 ident: 4034_CR21 publication-title: Brain Stimul doi: 10.1016/j.brs.2014.11.018 – volume: 8 start-page: 325 issue: 4 year: 2017 ident: 4034_CR29 publication-title: Frontline Gastroenterology doi: 10.1136/flgastro-2017-100809 – volume: 41 start-page: 951 issue: 9 year: 2011 ident: 4034_CR43 publication-title: Eur J Clin Invest doi: 10.1111/j.1365-2362.2011.02485.x – volume: 16 start-page: 626 issue: 10 year: 2016 ident: 4034_CR68 publication-title: Nat Rev Immunol doi: 10.1038/nri.2016.90 – volume: 1397 start-page: 19 year: 2011 ident: 4034_CR19 publication-title: Brain Res doi: 10.1016/j.brainres.2011.04.034 – volume: 112 start-page: 235 issue: 1 year: 1997 ident: 4034_CR41 publication-title: Chest doi: 10.1378/chest.112.1.235 – volume: 119 start-page: 637 issue: 4 year: 2017 ident: 4034_CR42 publication-title: Br J Anaesth doi: 10.1093/bja/aex239 – volume: 52 start-page: 18 year: 2016 ident: 4034_CR67 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2015.08.013 – volume: 6 start-page: e011014 issue: 7 year: 2016 ident: 4034_CR36 publication-title: BMJ Open doi: 10.1136/bmjopen-2015-011014 – volume: 10 start-page: 1511 issue: 15 year: 2017 ident: 4034_CR31 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2017.04.036 – volume: 111 start-page: e53913 year: 2016 ident: 4034_CR34 publication-title: J Vis Exp – volume: 62 start-page: 1 issue: 2 year: 2021 ident: 4034_CR35 publication-title: Eur Surg Res – volume: 80 start-page: 203 issue: 2 year: 2021 ident: 4034_CR53 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-217872 – volume: 13 start-page: 772 year: 2019 ident: 4034_CR52 publication-title: Front Neurosci doi: 10.3389/fnins.2019.00772 – volume: 11 start-page: 63 issue: 1 year: 2013 ident: 4034_CR66 publication-title: J Transl Med doi: 10.1186/1479-5876-11-63 – volume: 10 start-page: 19 issue: 1 year: 2017 ident: 4034_CR20 publication-title: Brain Stimul doi: 10.1016/j.brs.2016.10.008 – volume: 44 start-page: 3167 issue: 9 year: 2020 ident: 4034_CR60 publication-title: World J Surg doi: 10.1007/s00268-020-05543-w – volume: 15 start-page: 1 issue: 1 year: 2001 ident: 4034_CR4 publication-title: Shock (Augusta, Ga) doi: 10.1097/00024382-200115010-00001 – volume: 269 start-page: 45 issue: 1 year: 2011 ident: 4034_CR44 publication-title: J Intern Med doi: 10.1111/j.1365-2796.2010.02321.x – volume: 14 start-page: e0220397 issue: 8 year: 2019 ident: 4034_CR62 publication-title: PLoS ONE doi: 10.1371/journal.pone.0220397 – volume: 133 start-page: 1219 issue: 4 year: 2007 ident: 4034_CR11 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.07.022 – volume: 320 start-page: 700 issue: 5 year: 2021 ident: 4034_CR28 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00426.2020 – volume: 6 start-page: 303 issue: 4 year: 2000 ident: 4034_CR63 publication-title: J Endotoxin Res doi: 10.1177/09680519000060040501 – volume: 40 start-page: 519 issue: 6 year: 2013 ident: 4034_CR45 publication-title: Shock (Augusta, Ga) doi: 10.1097/SHK.0000000000000063 – volume: 18 start-page: 149 issue: 2 year: 1994 ident: 4034_CR59 publication-title: Epilepsy Res doi: 10.1016/0920-1211(94)90007-8 – volume: 19 start-page: 1 issue: 1 year: 2015 ident: 4034_CR7 publication-title: Crit Care doi: 10.1186/s13054-014-0721-8 – volume: 29 start-page: e12999 issue: 5 year: 2017 ident: 4034_CR33 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.12999 – volume: 9 start-page: 675 issue: 11 year: 2012 ident: 4034_CR10 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2012.134 – volume: 23 start-page: 1225 issue: 5 year: 2021 ident: 4034_CR61 publication-title: Colorectal Dis doi: 10.1111/codi.15561 – volume: 36 start-page: 5 issue: 1 year: 2011 ident: 4034_CR38 publication-title: Shock doi: 10.1097/SHK.0b013e3182168d56 – volume: 11 start-page: 520 issue: 1 year: 2006 ident: 4034_CR6 publication-title: Front Biosci doi: 10.2741/1816 – volume: 34 start-page: 417 issue: 3 year: 2019 ident: 4034_CR30 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-018-3204-6 – volume: 28 start-page: 948 issue: 6 year: 2016 ident: 4034_CR17 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.12792 – volume: 195 start-page: 172 year: 2016 ident: 4034_CR26 publication-title: J Affect Disord doi: 10.1016/j.jad.2016.02.031 – volume: 20 start-page: 678 issue: 4 year: 2016 ident: 4034_CR58 publication-title: Eur J Paediatr Neurol doi: 10.1016/j.ejpn.2016.02.014 – volume: 405 start-page: 458 issue: 6785 year: 2000 ident: 4034_CR9 publication-title: Nature doi: 10.1038/35013070 – volume: 155 start-page: 799 issue: 9 year: 2020 ident: 4034_CR65 publication-title: JAMA Surg doi: 10.1001/jamasurg.2020.0808 – volume: 29 start-page: e13075 issue: 9 year: 2017 ident: 4034_CR13 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13075 – volume: 131 start-page: 79 issue: 2 year: 2015 ident: 4034_CR37 publication-title: Nephron doi: 10.1159/000435843 – volume: 65 start-page: 867 issue: 9 year: 2015 ident: 4034_CR32 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.12.026 – volume: 38 start-page: 1336 issue: 12 year: 2007 ident: 4034_CR1 publication-title: Injury doi: 10.1016/j.injury.2007.10.003 – volume: 74 start-page: 107 issue: 2 year: 2017 ident: 4034_CR8 publication-title: J Infect doi: 10.1016/j.jinf.2016.11.006 – volume: 15 start-page: 35 issue: 1 year: 2002 ident: 4034_CR18 publication-title: Clin Anat doi: 10.1002/ca.1089 – volume: 163 start-page: 1007 issue: 5 year: 2011 ident: 4034_CR12 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2011.01296.x – volume: 17 start-page: 150 issue: 1 year: 2015 ident: 4034_CR39 publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0667-5 – volume: 30 start-page: 2279 issue: 12 year: 2004 ident: 4034_CR64 publication-title: Intensive Care Med doi: 10.1007/s00134-004-2477-0 – volume: 13 start-page: 251 issue: 5 year: 2007 ident: 4034_CR46 publication-title: J Endotoxin Res doi: 10.1177/0968051907085986 – volume: 38 start-page: 651 issue: 5 year: 2008 ident: 4034_CR56 publication-title: Psychol Med doi: 10.1017/S0033291707001924 – volume: 85 start-page: 1559 issue: 7 year: 2019 ident: 4034_CR40 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13941 – volume: 40 start-page: 144 issue: 2 year: 2013 ident: 4034_CR15 publication-title: Shock doi: 10.1097/SHK.0b013e318299e9c0 – volume: 23 start-page: 330 issue: 4 year: 2011 ident: 4034_CR5 publication-title: Neurogastroenterol Motil doi: 10.1111/j.1365-2982.2010.01653.x – volume: 28 start-page: 592 issue: 4 year: 2016 ident: 4034_CR27 publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.12760 – volume: 78 start-page: 1 issue: 1 year: 2012 ident: 4034_CR3 publication-title: Am Surg doi: 10.1177/000313481207800102 – volume: 103 start-page: 326 issue: 3 year: 2018 ident: 4034_CR51 publication-title: Exp Physiol doi: 10.1113/EP086433 – volume: 53 start-page: 104 issue: 3 year: 2008 ident: 4034_CR50 publication-title: Biomed Tech (Berl) doi: 10.1515/BMT.2008.022 – volume: 13 start-page: 293 issue: 5 year: 2012 ident: 4034_CR47 publication-title: Surg Infect doi: 10.1089/sur.2012.155 – volume: 53 start-page: e115 issue: 7 year: 2012 ident: 4034_CR24 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2012.03492.x – volume: 16 start-page: 63 issue: 1 year: 2015 ident: 4034_CR23 publication-title: J Headache Pain doi: 10.1186/s10194-015-0543-3 – volume: 11 start-page: 492 issue: 3 year: 2018 ident: 4034_CR22 publication-title: Brain Stimul doi: 10.1016/j.brs.2017.12.009 – volume: 40 start-page: 1452 issue: 10 year: 1999 ident: 4034_CR57 publication-title: Epilepsia doi: 10.1111/j.1528-1157.1999.tb02019.x |
SSID | ssj0017674 |
Score | 2.3339853 |
Snippet | Purpose
Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal... Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal paralysis... Purpose Surgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal... PurposeSurgery initiates pro-inflammatory mediator cascades leading to a variably pronounced sterile inflammation (SIRS). SIRS is associated with intestinal... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 259 |
SubjectTerms | Analysis Clinical Study Protocol Clinical trials Cytokines Endotoxemia Gastroenterology Health aspects Healthy Volunteers Hepatology Humans Infection Inflammation Internal Medicine Intestinal Failure Intestine Lipopolysaccharides Male Medical research Medicine Medicine & Public Health Medicine, Experimental Medicine, Preventive Mimicry Paralysis Peristalsis Pilot Projects Population studies Preventive health services Proctology Prophylaxis Prospective Studies Randomized Controlled Trials as Topic Reproducibility of Results Sepsis Standardization Surgery Systemic inflammatory response syndrome Systemic Inflammatory Response Syndrome - prevention & control Transcutaneous Electric Nerve Stimulation Vagus nerve Vagus Nerve Stimulation |
Title | Transcutaneous vagal nerve simulation to reduce a systemic inflammatory response syndrome and the associated intestinal failure: study protocol of a prospective, two-armed, sham-controlled, double-blinded trial in healthy subjects (the NeuroSIRS-Study) |
URI | https://link.springer.com/article/10.1007/s00384-021-04034-1 https://www.ncbi.nlm.nih.gov/pubmed/34599686 https://www.proquest.com/docview/2619747035 https://www.proquest.com/docview/2578766961 https://pubmed.ncbi.nlm.nih.gov/PMC8760201 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dixMxEA9yB-KL-G31PEYQVGygu_nYXd_Kceep6INn4XxakmyWK7S70o877n_3wZk0Xd2igi-FNl-zzS-TzM7ML4y9cL7InJY1F7ktODnmuLEKDVfnazSCbK1NCJD9rE8n8sO5Oo80OZQLs-O_J7JPkUtOgQQINyE5Wjr7injGyDGrjzqPAZHShHDFrOBEoBITZP7cR28T2lXFv-1Fu3GSO87SsAed3GG34-ERxpvZvstu-OYeu_kpusfvsx9h53FrPPB5tOjh0uCg0FBQIyyn83hTF6xaWBBjqwcDGybnqQNEGoJjHpzuWBwiZ7FVJDQA01SAZ0UwcTp9BcQ0gQqCJKrNlMLb30JgqwUif2gRYdDWOAR-2-ZzDmF11XKzwKcdwvLCzHkMlZ_RD1W7tjPP7YwoHHE4Whs4CmxyNa9hubb01mgJr0iSQCty9v7LGadYyOvXD9jk5Pjr0SmP1ztwp2Sy4hVdkWNsoZwemaTSoraZShUq3Fwr70UhRrmkqkpXqdS5IC4844zBU09Oqugh22vaxj9mYISvq6RyWtiRzEbOWpenXmVOEr1-LQcs2c536SL3OV3BMSs71uaAkRIxUgaMlMmAvenafN8wf_yz9kuCUUlqAXt2JmY3oHxEsFWOM7RcUTcqlOWgVxOXs-sXb4FYRnWyLMnMRbtvJNSAPe-KqSWFyAVIlUH3al1olOXRBred3EISC0-uByzrIbqrQCTj_ZJmehHIxrFPtCiwz-EW-7_E-vvf8eT_qj9lt1JKKwmvtg7Y3mqx9s_wsLeyh2x__O7bx-PDsNrxc5KOfwJFJVIJ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfQkIAXxDeFAYeEBIhaahvbSXirEFMH2x7YKu3Nsh1Hq9QmqGk37X_ngTvXCbQCJB5bf13rX853ubufGXvjfJ46JUqeZDbnFJjjxkp0XJ0v0QmypTIhQfZETabiy7k8j0VhTZvt3oYkg6buit0oiCU4pRQg8BLB0ee5icZARriejsZd7IDoaULiYppzolKJpTJ_nmPrONpVyr-dSrsZkzth03AaHdxjd6MZCePNvt9nN3z1gN06joHyh-xHOIPcGk0_j749XBpcFCpKb4Rmtoh3dsGqhiVxt3owsOF0njlAzCFMFiH8js0hhxZHRWoDMFUBaDWCiRvrCyDOCVQVJFFpZpTo_hECby0QDUSNWIO6xCXwU1vZ2YfVVc3NEn9tH5oLs-AxaX5OXxT12s49t3Mic8Tl6CnBVWBTtXkNzdrS-6MG3pEkgWDk9PDbKaesyOv3j9j04PPZpwmPFz1wJ8VwxQu6LMfYXDo1MMNCJaVN5Uii6s2U9D7Jk0EmqKtUxUioLCFWPOOMQfsnI6X0mO1VdeWfMjCJL4th4VRiByIdOGtdNvIydYKI9kvRY8N2v7WLLOh0Gcdcd_zNASMaMaIDRvSwxz50Y75vOED-2fstwUiTgsCZnYl1DigfUW3pcYo-LGpJibLsb_XEB9ttN7dA1FGxNJocXvQAB4nssdddM42kZLkAKR20sFK5QlmebHDbyZ0I4uPJVI-lW4juOhDd-HZLNbsItOM4J_oWOGe_xf4vsf7-dzz7v-6v2O3J2fGRPjo8-fqc3RlRsUl44bXP9lbLtX-BJuDKvgxP_E9S0Vaa |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfQJk28IMZnx4BDQgJErTVN7CS8VUC18TEhRqW9WbbjaJXaZGpT0P53Hrhz3LBWgMRj669r8_P5Lnf3M2PPrctTK5OSx5nJOQXmuDYCHVfrSnSCTCm1T5A9lceT5MO5OL9Wxe-z3dchybamgViaqubosiiPusI3CmglnNILEIRxwtH_2UV1HJH7NRmOujgCUdX4JMY050SrEspm_jzHxtG0raCvnVDb2ZNbIVR_Mo1vs1vBpIRRi4F9dsNVd9je5xA0v8t--vPIrtAMdOjnw3eNi0JFqY6wnM7D_V3Q1LAgHlcHGlp-56kFxB9CZu5D8djs82lxVKA5AF0VgBYk6PCQXQHEP4FqgyQq9ZSS3t-A57AFooSoEXdQl7gEflpXefah-VFzvcBf24flhZ7zkEA_oy-KemVmjpsZETvicrRjcBVoKzivYLky9C5pCS9JEk82cnby9YxThuTVq3tsMn7_7e0xD5c-cCuSqOEFXZyjTS6sHOiokHFpUjEUqIYzKZyL83iQJdRVyGKYyCwmhjxttUZbKCMFdZ_tVHXlHjLQsSuLqLAyNoMkHVhjbDZ0IrUJke6XSY9F6-etbGBEp4s5ZqrjcvYYUYgR5TGioh573Y25bPlA_tn7BcFIkbLAma0ONQ8oH9FuqVGK_ixqTIGyHG70xE1uN5vXQFRBySwVOb_oDQ5i0WPPumYaSYlzHlLKa2Qpc4myPGhx28kdJ8TNk8keSzcQ3XUg6vHNlmp64SnIcU70M3DO_hr7v8X6-99x8H_dn7K9L-_G6tPJ6cdH7OaQ6k78u69DttMsVu4xWoONeeI3_C_8K1rW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcutaneous+vagal+nerve+simulation+to+reduce+a+systemic+inflammatory+response+syndrome+and+the+associated+intestinal+failure%3A+study+protocol+of+a+prospective%2C+two-armed%2C+sham-controlled%2C+double-blinded+trial+in+healthy+subjects+%28the+NeuroSIRS-Study%29&rft.jtitle=International+journal+of+colorectal+disease&rft.au=van+Beekum%2C+Cornelius+J&rft.au=von+Websky%2C+Martin+W&rft.au=Willis%2C+Maria+A&rft.au=Panknin%2C+Christina&rft.date=2022-01-01&rft.issn=1432-1262&rft.eissn=1432-1262&rft.volume=37&rft.issue=1&rft.spage=259&rft_id=info:doi/10.1007%2Fs00384-021-04034-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-1958&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-1958&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-1958&client=summon |